ACE-031

If you are engaged in musculoskeletal or metabolic research, you should seriously consider whether to buy ACE-031 for your laboratory studies. This recombinant fusion protein represents a significant molecular tool for studying negative regulators of skeletal muscle mass. When you buy ACE-031, you are acquiring a soluble ActRIIB decoy receptor that binds myostatin and related ligands with high affinity. This guide covers the mechanism, research applications, and where to buy ACE-031 from trusted suppliers.

Understanding the Mechanism: How ACE-031 Works

ACE-031 promotes muscle growth by binding to myostatin (GDF-8) and other negative regulators of muscle mass. This binding prevents these ligands from interacting with endogenous cell-surface receptors. Essentially, ACE-031 acts as a “decoy receptor” that sequesters these inhibitory molecules. In preclinical studies, this mechanism delivered impressive results: ACE-031 treatment led to a 16% increase in mean body weight and up to 46% increases in muscle wet weights in mice. Consequently, researchers continue to buy ACE-031 for studies on muscle hypertrophy and wasting conditions.

Key Research Findings

Phase I Clinical Study in Healthy Volunteers

A double-blind, placebo-controlled study evaluated ACE-031 in 48 healthy, postmenopausal women. Single-dose treatment proved generally well-tolerated and produced statistically significant increases in mean total body lean mass (3.3%; P = 0.03) and thigh muscle volume (5.1%; P = 0.03) at day 29 in the 3 mg/kg group. For this reason, many investigators choose to buy ACE-031 for translational muscle research.

Duchenne Muscular Dystrophy Study

In a trial with ambulatory boys with Duchenne muscular dystrophy, ACE-031 showed promising trends for pharmacodynamic effects on lean mass, fat mass, bone mineral density, and maintenance of the 6-minute walk test distance. Nevertheless, the study was discontinued due to potential safety concerns of epistaxis and telangiectasias, though no serious or severe adverse events were reported. Despite this setback, researchers continue to buy ACE-031 for preclinical investigations.

Non-Human Primate Study

In common marmosets, ACE-031 administration over 14 weeks led to significant increases in lean body mass, cross-sectional area of muscle fibers, and absolute and specific force production. Consequently, this primate data strengthens the rationale for further research.

Dosing and Administration

For research applications, ACE-031 is available as a 1mg lyophilized powder. Standard storage conditions require -20°C for long-term storage, with reconstituted solutions stable at -80°C for up to 6 months. Typical research dosing protocols range from 0.02 to 3 mg/kg subcutaneous, with studies monitoring effects over 14 to 29 days. Therefore, when you buy ACE-031, you should carefully plan your storage and handling protocols.

Safety Profile

In published studies, ACE-031 generally demonstrated good tolerability. Reported adverse events include injection site erythema in healthy volunteers. In the DMD trial, the study stopped due to potential safety concerns of epistaxis and telangiectasias, though no serious or severe adverse events occurred. Consequently, researchers should exercise appropriate caution when designing their studies.

Important Considerations

ACE-031 is intended strictly for laboratory research purposes only. It is not approved by the FDA for human use, nor is it intended as a drug, food additive, or cosmetic. All sales are for research use only by qualified researchers in a controlled laboratory environment. For this reason, only qualified investigators should buy ACE-031.

https://images.unsplash.com/photo-1576091160550-2173dba999ef?w=800&q=80
Alt text: Research protocol diagram showing ACE-031 administration and study endpoints, helping investigators understand why to buy ACE-031 for their research.

Take the Next Step – Buy ACE-031 for Your Research Today

The scientific evidence strongly supports ACE-031 as a valuable tool for investigating myostatin and activin signalling pathways, muscle growth regulation, and potential therapeutic applications for muscle-wasting conditions. Furthermore, the preclinical data demonstrate consistent efficacy across multiple model systems. If you are a qualified researcher ready to advance your studies, buy ACE-031 today from a trusted supplier offering third-party tested material with ≥99% purity.

https://images.unsplash.com/photo-1588776814546-1ffcf47267a5?w=800&q=80
Alt text: Molecular structure diagram of ACE-031 showing the ActRIIB-Fc fusion protein, highlighting why researchers buy ACE-031 for myostatin studies.

Internal Resources

• Understanding Myostatin Inhibition and Muscle Growth – Deep dive into the science of myostatin pathways before you buy ACE-031.

• GLP-1 and Muscle Preservation Strategies – Compare approaches for maintaining lean mass.

• Research Peptide Handling and Storage Guide – Best practices for lyophilized peptides when you buy ACE-031.

• Precision Peptide Genetic Test for GLP-1 Response – Discover genetic factors affecting muscle research.

• Weight Management Protocols – Learn about comprehensive metabolic research protocols.

• NAD+ Boosting Strategies Guide – Compare metabolic research compounds.

• Muscle Atrophy Research Models – Understand experimental systems.

• ActRIIB Signaling Pathway Overview – Detailed pathway analysis.

External Resources and Links

• PubMed: Single Ascending-Dose Study of ACE-031 – Phase I clinical data in healthy volunteers.

• PubMed: Duchenne Muscular Dystrophy Trial – Clinical results in DMD patients.

• PubMed: Non-Human Primate Study – ACE-031 efficacy in marmosets.

• PubMed: ACE-031 Mechanism of Action – Regulation of muscle growth by activin receptors.

• NCBI: METTL3 and Myostatin Inhibition – Rescue of hypertrophy defects with myostatin inhibition.

• ChemicalBook: ACE-031 Product Information – Technical specifications and supplier information.

• PeptiFy Labs: ACE-031 Product Page – Research-grade ACE-031 with third-party testing.

• OP Labs: ACE-031 Specifications – Detailed molecular and handling information.

• FDA MedWatch: Report Adverse Events – Essential for reporting any research-related issues.